08:11 AM EST, 11/12/2025 (MT Newswires) -- CorMedix ( CRMD ) reported Q3 earnings Wednesday of $1.26 per diluted share, swinging from a loss of $0.05 a year earlier.

One analyst polled by FactSet expected $0.95.

Revenue for the quarter ended Sept. 30 was $104.3 million, compared with $11.5 million a year earlier. Analysts surveyed by FactSet expected $86 million.

For Q4, the company expects net revenue in the range of $115 million to $135 million. Analysts surveyed by FactSet expect $118.8 million.

CorMedix ( CRMD ) said it now expects full-year 2025 pro forma net revenue of $390 million to $410 million, compared with the prior estimate of $375 million. Analysts polled by FactSet expect $283.7 million.

CorMedix ( CRMD ) shares were up more than 6% in recent Wednesday pre-bell activity.